Astrana Health, Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 23, 2026. The filing discloses the company’s updated corporate presentation and confirms the existence of a material weakness in its internal control over financial reporting.
Under Item 7.01 of the report, the company stated that it updated its corporate presentation on September 23, 2026, to be used for future conference presentations. The presentation, attached as Exhibit 99.1, details the company’s strategy to build a coordinated healthcare system. Astrana reports it manages approximately 1.5 million members and has a network of more than 20,000 providers across 18 markets nationwide. The company states it partners with over 20 payers and utilizes an AI-native clinical operating system to manage the total cost of care.
Item 9.01 of the filing lists the exhibits. Exhibit 99.1 is identified as the Investor Presentation for September 2026. The company also notes that the presentation contains forward-looking statements regarding its business, financial condition, operating results, and projections of earnings, revenue, expenses, EBITDA, and other financial items.
The company also disclosed that its presentation addresses the material weakness in internal control over financial reporting. The filing notes that the company is unable to provide a quantitative reconciliation of applicable non-GAAP financial measures, such as projected adjusted EBITDA to GAAP net income, on a forward-looking basis without unreasonable efforts due to the inherent uncertainty of certain items.
